Profusa, Inc. Common Stock (PFSA)
Oxford Ledge is still expanding full research coverage of PFSA. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Profusa develops injectable biosensor technology for real-time health monitoring, with its first product approved in Europe and FDA approval being pursued in the U.S.
SEC filings
- 8-K 3.03; Amendments to articles or bylaws; Other material event; Financial statements and exhibits 2026-07-06
- 8-K Shareholder vote results 2026-06-23
- 8-K Other material event 2026-06-08
- DEF 14A Proxy statement for shareholder vote 2026-05-26
- 8-K Entry into material agreement; Financial statements and exhibits 2026-05-26
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for PFSA. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open PFSA in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.